The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis
- PMID: 29402832
- PMCID: PMC5861351
- DOI: 10.1159/000487120
The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis
Abstract
Background/aims: The CFTR-Associated Ligand (CAL), a PDZ domain containing protein with two coiled-coil domains, reduces cell surface WT CFTR through degradation in the lysosome by a well-characterized mechanism. However, CAL's regulatory effect on ΔF508 CFTR has remained almost entirely uninvestigated.
Methods: In this study, we describe a previously unknown pathway for CAL by which it regulates the membrane expression of ΔF508 CFTR through arrest of ΔF508 CFTR trafficking in the endoplasmic reticulum (ER) using a combination of cell biology, biochemistry and electrophysiology.
Results: We demonstrate that CAL is an ER localized protein that binds to ΔF508 CFTR and is degraded in the 26S proteasome. When CAL is inhibited, ΔF508 CFTR retention in the ER decreases and cell surface expression of mature functional ΔF508 CFTR is observed alongside of enhanced expression of plasma membrane scaffolding protein NHERF1. Chaperone proteins regulate this novel process, and ΔF508 CFTR binding to HSP40, HSP90, HSP70, VCP, and Aha1 changes to improve ΔF508 CFTR cell surface trafficking.
Conclusion: Our results reveal a pathway in which CAL regulates the cell surface availability and intracellular retention of ΔF508 CFTR.
Keywords: Endoplasmic reticulum; F508-del CFTR; Maturation; PDZ-domain; Trafficking.
© 2018 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
Figures










Similar articles
-
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.Biochemistry. 2008 Sep 23;47(38):10084-98. doi: 10.1021/bi8003928. Epub 2008 Aug 29. Biochemistry. 2008. PMID: 18754678 Free PMC article.
-
ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.J Biol Chem. 2011 Jun 17;286(24):21239-53. doi: 10.1074/jbc.M111.240267. Epub 2011 Apr 27. J Biol Chem. 2011. PMID: 21525008 Free PMC article.
-
Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.Am J Physiol Cell Physiol. 2000 Feb;278(2):C259-67. doi: 10.1152/ajpcell.2000.278.2.C259. Am J Physiol Cell Physiol. 2000. PMID: 10666020
-
Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi.FEBS J. 2013 Sep;280(18):4396-406. doi: 10.1111/febs.12392. Epub 2013 Jul 5. FEBS J. 2013. PMID: 23773658 Review.
-
Regulated trafficking of the CFTR chloride channel.Eur J Cell Biol. 2000 Aug;79(8):544-56. doi: 10.1078/0171-9335-00078. Eur J Cell Biol. 2000. PMID: 11001491 Review.
Cited by
-
Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.Int J Mol Sci. 2020 Jan 10;21(2):452. doi: 10.3390/ijms21020452. Int J Mol Sci. 2020. PMID: 31936842 Free PMC article. Review.
-
Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis.Front Pharmacol. 2018 Oct 1;9:1112. doi: 10.3389/fphar.2018.01112. eCollection 2018. Front Pharmacol. 2018. PMID: 30327603 Free PMC article. Review.
-
The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.J Biomed Sci. 2024 Jun 27;31(1):64. doi: 10.1186/s12929-024-01054-1. J Biomed Sci. 2024. PMID: 38937821 Free PMC article. Review.
-
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.Front Pharmacol. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662. eCollection 2019. Front Pharmacol. 2020. PMID: 32153386 Free PMC article. Review.
-
Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.J Phys Chem B. 2019 Dec 12;123(49):10441-10455. doi: 10.1021/acs.jpcb.9b07278. Epub 2019 Nov 27. J Phys Chem B. 2019. PMID: 31697075 Free PMC article.
References
-
- Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buckwald M, Tsui LC. Identification of the cystic fibrosis gene: Genetic analysis. Sci. 1989;245:1073–1080. - PubMed
-
- Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev. 1999;79:S215–S255. - PubMed
-
- Rosenstein BJ. Cystic fibrosis diagnosis: New dilemmas for an old disorder. Ped Pulm. 2002;33:83–84. - PubMed
-
- Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev. 1999;79:S23–S45. - PubMed
-
- Sosnay PR, Siklosi KR, Van GF, Kaniecki K, Yu H, Sharma N, Ramalho AS, Amaral MD, Dorfman R, Zielenski J, Masica DL, Karchin R, Millen L, Thomas PJ, Patrinos GP, Corey M, Lewis MH, Rommens JM, Castellani C, Penland CM, Cutting GR. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45:1160–1167. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous